Recurrence prevention after venous thromboembolism: Apixaban beats rivaroxaban

被引：0
|
作者：
Ruchalla, Elke
机构：
来源：
PHLEBOLOGIE | 2025年 / 54卷 / 02期
关键词：
D O I：
10.1055/a-2479-8820
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：54 / 56
页数：3
相关论文
共 50 条
  • [31] Fatigue after initiating rivaroxaban for venous thromboembolism
    Karlsvik, Tina Margrethe
    Borgenvik, Thore Langfeldt
    Aadalen, Mirjam
    Utne, Kristin
    Forsund, Eli
    Jorgensen, Camilla Tovik
    Holst, Rene
    Jelsness-Jorgensen, Lars-Petter
    Ghanima, Waleed
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2020, 4 (04) : 582 - 585
  • [32] PRACTICAL USE OF APIXABAN IN THE PREVENTION OF VENOUS THROMBOEMBOLISM AFTER TOTAL KNEE OR HIP REPLACEMENT
    Lassen, M. R.
    DRUGS OF TODAY, 2012, 48 (04) : 249 - 258
  • [33] Venous thromboembolism Risk of recurrence lower with rivaroxaban than aspirin
    Huynh, Karina
    NATURE REVIEWS CARDIOLOGY, 2017, 14 (05) : 3 - 3
  • [34] Evaluation of Low-Dose Apixaban for Prevention of Venous Thromboembolism After Lung Transplant
    Cairns, T.
    Smith, L.
    Truax, C.
    Larson, T.
    Eiting, M.
    Heinen, K.
    Zukauckas, K.
    Chan, A.
    Sirandas, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S1025 - S1026
  • [35] Comparison of apixaban, dabigatran and rivaroxaban in the acute treatment and prevention of venous thromboembolism: systematic review and network meta-analysis
    Cohen, A.
    Fowler, H.
    Hamilton, M.
    Phatak, H.
    Mitchell, S. A.
    Liu, X. C.
    Claflin, A.
    Reason, T.
    EUROPEAN HEART JOURNAL, 2014, 35 : 1064 - 1064
  • [36] Effectiveness and safety of apixaban versus rivaroxaban for prevention of recurrent venous thromboembolism and adverse bleeding events in patients with venous thromboembolism: a retrospective population-based cohort analysis
    Dawwas, Ghadeer K.
    Brown, Joshua
    Dietrich, Eric
    Park, Haesuk
    LANCET HAEMATOLOGY, 2019, 6 (01): : E20 - E28
  • [37] Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement
    Eriksson, B. I.
    Kakkar, A. K.
    Turpie, A. G. G.
    Gent, M.
    Bandel, T. -J.
    Homering, M.
    Misselwitz, F.
    Lassen, M. R.
    JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 2009, 91B (05): : 636 - 644
  • [38] From apixaban to aspirin in the prevention of recurrent venous thromboembolism.
    Diez-Ewald, Maria
    INVESTIGACION CLINICA, 2013, 54 (03): : 231 - 233
  • [39] Dabigatran, rivaroxaban and apixaban for extended venous thromboembolism treatment: network meta-analysis
    Alotaibi, G.
    Alsaleh, K.
    Wu, C.
    McMurtry, M. S.
    INTERNATIONAL ANGIOLOGY, 2014, 33 (04) : 301 - 308
  • [40] Comparative effectiveness and safety of edoxaban, rivaroxaban, and apixaban in patients with venous thromboembolism: A cohort study
    Fukasawa, Toshiki
    Seki, Tomotsugu
    Nakashima, Masayuki
    Kawakami, Koji
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2022, 20 (09) : 2083 - 2097
12345